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Abstract:  The aim of this work was to study the influence of the different synthesis processes on 
microstructural and morphological characteristics and distribution of hydroxyapatite-bioactive glass 
(HAp-BG) composite nanopowders obtained by sol–gel method. HAp-BG composite nanopowders 
with 20 wt% bioactive glass were prepared using a sol–gel method via four routes: (I) mixing the 
prepared HAp solution with BG solution before aging time; (II) mixing the prepared BG solution with 
the prepared HAp gel after gelation; (III) mixing the calcined BG nanopowders with the prepared 
HAp solution; and (IV) mixing the two prepared calcined nanopowders by mechanochemical 
activation. The prepared nanopowders were evaluated and studied by X-ray diffraction (XRD), 
scanning electron microscopy (SEM), energy dispersive X-ray spectrometer (EDS), Fourier transform 
infrared (FTIR), transmission electron diffraction (TEM) and Brunauer–Emmet–Teller (BET) method 
to investigate the phase structure, microstructure and morphology, functional groups, and the size and 
distribution of nanopowders. Results indicated that morphology, crystallinity, crystallite size and 
specific surface area (SSA) of the powders are highly correspondent to the process and type of 
synthesis method. These findings suggest that the modified sol–gel derived HAp-BG composite 
nanopowders are expected to efficiently provide a possibility to produce a good candidate to use for 
fabrication of a bulk nanostructured HAp-BG composite for bone tissue engineering. 
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1	 	 Introduction	
The hard tissues of bones are composed of calcium 
phosphate minerals which play vital roles during bone 
metabolism. These inorganic minerals mechanically 
support the body and provide the essential ions into the 
body fluids to maintain homeostasis [1]. A great deal 
of research has shown that calcium phosphates and 
their derivatives (such as hydroxyapatite) can provide a 
desirable environment for bone tissue regeneration due 
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to their similarity in chemistry to natural bone, enamel 
and dentine [2]. Due to the large surface area to 
volume ratio of nanometer-sized particles, it has been 
found that nanostructured biomaterials increase 
mechanical reliability, osteoblast cell adhesion, 
proliferation and mineralization compared with their 
conventional micron-scale counterparts [3,4]. 
A major component of the inorganic part of natural 
bone is composed of nanostructured hydroxyapatite 
(HAp, Ca10(PO4)6(OH)2)) crystals of approximately 
50 nm in length and 5 nm in diameter [2]. A successful 
bone regeneration of the applied biomaterials depends 
on the cell proliferation, differentiation and 
mineralization of the extracellular matrix [5]. 
Nanostructured HAp interacts with osteoblast cells and 
mimics the structure of the natural extracellular matrix. 
Moreover, research has shown that the nanocrystalline 
HAp enhances osteoblast adhesion and proliferation 
compared to conventional micron-sized HAp [6]. 
However, medical applications of HAp have been 
limited because of its low mechanical properties and 
slow rate of osseointegration [7]. Ideal orthopedic 
biomaterials should improve the mechanical properties 
and bioactivity during implantation. Currently, 
bioactive glass and hydroxyapatite are two main 
bioactive materials for bone regeneration therapies [8]. 
Incorporation of bioactive glass (BG) particles 
endows particular properties to HAp, such as 
improving bioactivity and mechanical properties [9]. 
The certain composition of bioactive glasses 
containing SiO2–CaO–P2O5 has found wide 
applications as bone implants [10]. Results of in vivo 
implantation show that these compositions bond to 
tissues without an intervening fibrous layer and 
produce no local or systemic toxicity [11]. Introduction 
of silicate ions into the HAp structure improves in vivo 
bioactivity and induces both osteogenesis and 
angiogenesis during bone regeneration [7,12]. 
Recently, sol–gel technique as a wet chemical 
method has been widely applied for synthesis of 
bioceramic nanopowders. The crystalline degree and 
morphology of the sol–gel derived nanopowders can 
be controlled by a number of parameters including the 
intrinsic properties of the solution (e.g., the type of 
bioceramics, the conformation of bioceramic 
concentration) and the operational conditions (e.g., the 
hydrolysis time, the sequence of reactions) [13,14]. 
The aim of present research was to evaluate and 
compare the effect of different synthesis processes on 
microstructural and morphological characteristics and 
distribution of hydroxyapatite-bioactive glass 
(HAp-BG) composite nanopowders obtained by 
sol–gel method. Based on the obtained results, the 




The preparation of the sol–gel derived HAp and 
bioactive glass powders was slightly modified from 
our previous works and published reports [15–17]. In 
brief, as sol–gel precursors for HAp, calcium nitrate 
tetrahydrate (Ca(NO3)2·4H2O, Merck) and phosphoric 
pentoxide (P2O5, Merck) were used. Both were 
hydrolyzed separately in ethanol (Et(OH), Merck), and 
then mixed at a Ca/P ratio of 1.67, and stirred for 2 h. 
The mixture was continuously stirred for 24 h at 
ambient temperature. This process was called aging. 
The gel was dried at 80 ℃ for 24 h. 
The bioactive glass was prepared with the nominal 
composition (in mol%) of 46.1%SiO2–51.3%CaO–     
2.6%P2O5 by hydrolysis and polycondensation 
reactions of chemicals using reagent-grade tetraethyl 
orthosilicate (TEOS, Si(OC2H5)4, Merck), triethyl 
phosphate (TEP, OP(OC2H5)3, Merck), calcium nitrate 
tetrahydrate (Ca(NO3)2·4H2O, Merck), ethanol 
(Et(OH), Merck), hydrochloric acid (HCl, Merck) and 
deionized distilled water. The molar ratio of each 
compound was adjusted according to the molar ratio of 
SiO2, P2O5 and CaO within the designed bioactive 
glass. The precursors were added in sequence and 
stirred for at least 2 h to prepare a clear solution. The 
resulting gel was aged at 60 ℃ for 48 h and dried at 
120 ℃ for 48 h. 
The HAp-BG composite nanopowders were 
prepared using 20 wt% bioactive glass as 
reinforcement within the HA matrix by the following 
different routes: 
(I) Mixing HAp solution with BG solution before 
aging time (HBI); 
(II) Mixing BG solution with HAp gel after gelation 
(HBII); 
(III) Mixing calcined BG nanopowders with HAp 
solution (HBIII); 
(IV) Mixing calcined HAp and BG powders by 
mechanochemical activation (HBIV). 
The HBIV sample was produced using a 
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high-energy planetary ball mill (PM 100, Retsch, 
Germany) with a zirconia vial and zirconia balls via 
2 h mechanochemical activation to produce more 
homogenous composite nanopowders. Figure 1 
outlines the experimental procedure of the present 
study. 
2.	2	 	 Powder	characterization	
Structural changes of the samples (phase composition, 
crystallinity and crystallite size) were studied by X-ray 
diffraction analysis (XRD, Philips Xpert, the 
Netherlands) with Cu Kα radiation (λ = 0.15406 nm, 
radiation at 40 kV and 30 mA) over the 2θ range of 
20°–70° at a scan rate of 0.02 (°)/s. The obtained 
experimental patterns were compared to standards 
compiled by the Joint Committee on Powder 
Diffraction and Standards (JCDPS), which involved 
Card No. 9-432 for HAp. The fractions of crystalline 
phase of HAp in each sample were evaluated using the 
following equation [18]: 
c 112/300 3001 /X V I             (1) 
where 300I  is the intensity of the diffraction peak (300) 
and 112/300V  is the intensity of the hollow between 
diffraction peaks (112) and (300) of HAp phase. The 
size of the HAp crystallites responsible for the Bragg 
reflection of the (002) and (300) planes was 
determined using the well-known Scherrer’s equation 
[19]: 
s /( cos )X k B               (2) 
where sX  is the crystallite diameter (nm); k ,  , B  
and   are the shape constant (k = 0.89), the 
wavelength of X-ray beam ( = 1.5418 Å for Cu Kα 
radiation), the full width at half maximum for the 
diffraction peak (radian), and the diffraction angle 
(degree), respectively.  
The functional groups and chemical structure of the 
prepared powders were determined by Fourier 
transform-infrared spectroscopy (FTIR, Jasco-680, 
Japan). The IR spectra were run on KBr pellets, with a 
weight ratio of sample to KBr of 1:100. The spectrum 
was recorded in the range of 4000–400 cm−1 with a 
resolution of 1 cm−1. 
The microstructural features and elemental chemical 
composition of the powders were studied by scanning 
electron microscopy (SEM, Phillips XL30) attached 
with an energy dispersive X-ray spectroscopy (EDS, 
Seron Technology AIS 2300C, Korea) and an image 
analyzer software (ImageJ, National Institutes of 
Health, Bethesda, MD, USA). 
The morphology and particle size distribution of the 
powders were carried out by transmission electron 
microscopy (TEM, LEO 912 AB, Ziess, Germany) in 
bright field mode, with the accelerating voltage being 
120 kV. 
The specific surface area (SSA) of the ceramic 
powders was calculated according to Brunauer–      
Emmet–Teller (BET) method using Micromeritics 
Device (Norcross, USA). 
The primary particle size ( BETD ) was estimated by 
assuming the particles to be spherical [20]: 
BET 6/( )D ρS               (3) 
where ρ  is the theoretical density of the sample, and 
S  is the SSA. The ρ  value was determined by a 




Figure 2 shows the XRD patterns of the synthesized 
composite nanopowders. Since the bioactive glass 
phase is amorphous, no related peak can be observed 
in the XRD patterns. Thus the calculated fractions of 
crystalline phase ( cX ) and crystallite size ( sX ) of the 
HAp-BG nanopowders based on the diffraction peaks 
 
Fig. 1  Schematic illustration of four different 
preparing routes of composite nanopowders based 
on sol–gel method. 
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and using Scherrer’s formula respectively are listed in 
Table 1. The XRD investigation reveals that the 
fraction of crystalline phase of the final composite 
nanopowders is affected by the sequence of adding 
precursors. The crystallinity of the composite 
decreases in the presence of bioactive glass as the 
sintering temperature was set at 600 ℃ for all the 
samples. Silicon-containing ionic products of the 
bioactive glass can easily be released in the HAp sols. 
Andersson et al. [21] reported that the presence of 
silica in the solution slows down the HAp crystallite 
growth. Compared to the pure HAp and HAp-BG 
nanopowders, the composite nanopowders would be 
restricted in the crystallization owing to silica which 
acts as a barrier to crystallization against another phase 
by limiting atomic arrangement [22]. It is worth noting 
that the difference in crystallinity between HBIV 
sample and the pure HAp reported by Latifi et al. [23], 
is not distinct. Moreover, in situ synthesis (the HAp 
solutions including BG, i.e., HBI, HBII and HBIII 
samples) leads to decrease in the crystallite size of 
HAp-BG nanopowders. 
3.	2	 	 FTIR	spectroscopy	
FTIR spectra of the prepared composite nanopowders 
are presented in Fig. 3. The data obtained for bare pure 
HAp is also inserted in Fig. 3 for comparison. In 
general, the spectra do not show significant differences 
on absorption bands among the composite producing 
procedures. For all the specimens, the characteristic 
vibration bands of PO43− are observed at around 
560–570 cm−1, 600–610 cm−1, 960–970 cm−1 and 
1000–1100 cm−1, and OH− bands at around 460–     
480 cm−1, 620–640 cm−1 and 3520–3530 cm−1, showing 
typical HAp characteristics [16,24,25]. The bands at 
3300–3400 cm−1 correspond to H–O–H from water 
absorption of synthesis process [26]. A comparison 
between pure HAp and HAp-BG composite IR spectra 
shows that the intensity of characteristic bands 
decreases in composite nanopowders, which could be 
attributed to the presence of SiO2. In the composite 
nanopowders, the absorption bands around 1000–    
1100 cm−1 correspond to both P–O and Si–O–Si 
groups. Furthermore, the absorption bands in the range 
of 3200–3400 cm−1 indicating that the Si–OH groups 
are present in the composite nanopowder lattice 
structure [17,23]. It should be pointed out that HAp 
and silica share a number of superimposed vibrational 
bands, due to similarities of SiO4
4− and PO4
3− tetrahedral 
molecular units [23,27]. Thus, it would be difficult to 
distinguish SiO2 absorption bands because of stronger 
overlapping absorption bands of HAp. 
The characteristic bands of C–O group occur at 
860–880 cm−1 and 1400–1450 cm−1. A band at about 
875 cm−1 could be either CO3
2− or HPO4
2− groups. It 
suggests that CO3
2− ions are partly substituted with 
PO4
3− in the apatite structure and the amorphous 
complex [23]. The CO3
2− ions may be resulted from the 
incomplete pyrolysis of organic compounds or as a 
common contaminant from the atmosphere. They 
Table 1  Crystallinity and crystallite size of 
hydroxyapatite with 20 wt% bioglass nanopowders 
Sample Crystallite size (nm) Crystallinity (%) 
HBI 28 65 
HBII 55 66 
HBIII 54 66 
HBIV 58 70 
 
Fig. 2  XRD patterns of HAp-BG composite 
nanopowders. 
Position 2θ (°) 
 
Fig. 3  FTIR spectra of the hydroxyapatite 
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possibly penetrate within the composite structure 
during synthesis process [28,29]. The dissolution of 
CO2 from the atmosphere occurs by the following 
reaction: 
2
2 3 2CO (g) + 2OH (aq)  CO (aq) + H O(l)
     (4) 
Since carbonated apatite is more similar to the bone 
structure, the presence of CO3
2− may improve the 
bioactivity of the composition [30,31]. 
3.	3	 	 SEM	and	EDS	evaluation	
Figure 4 shows the morphological characteristics and 
elemental analyses of the prepared composite 
nanopowders. Large platelet or flake shape 
agglomerates are formed in the HBI sample due to the 
influence of short-range van der Waals forces during 
aging [20,32]. The size distribution range of HBI 
sample particles is approximately 10–300 nm. By 
changing the synthesis process of composite 
nanopowders, the plate like aggregates are converted 
into more uniform distribution of particles, especially 
for HBII and HBIII samples. The particle size 
distributions of the HBII, HBIII and HBIV samples are 
approximately achieved in the range of 15–130 nm, 
10–150 nm and 20–350 nm, respectively. Thus, HBIV 
sample has greater size of agglomerates. This 
observation could be explained by milling process. 
During the initial stage of milling, the rate of 
agglomeration is higher than that of fragmentation of 
fine particles due to higher rate of cold welding [33]. 
Generally speaking, the SEM micrographs of all the 
samples show that plenty of significantly fine particles 
are interconnected and form irregular agglomerated 
clusters. 
It should be noted that the fine and homogeneous 
microstructure is the initial important factor for 
improvement in mechanical properties and biomedical 
performance of bulk ceramics [34,35]. 
It has been demonstrated that the morphology and 
the degree of aggregation are attributed to the 
concentration and the rate of mixing applied to the 
solutions. From the view of the mentioned observation, 
it is expected that since the concentration of primary 
solutions and the mixing speed of the precursors are 
low, the final powders are toward the formation of 
non-agglomerated particles [28], while our observation 
reveals that the overall mixing procedure is another 
important factor which determines the morphological 
characteristics. 
Since the bioglass nanopowders are added within the 
hydroxyapatite solution (HBII and HBIII samples), the 
HAp nanoparticles start to deposit on the surface of the 
heterogeneous nucleation sites [36]. It is confirmed 
that SiO2 in the bioglass structure can inhibit the HAp 
particle growth [21,28]. Thus, fine and well distributed 
spherical shape is produced in the HBII and HBIII 
samples. 
As shown in Fig. 4, the existence of Ca, P, O and Si 
in the EDS analysis is related to hydroxyapatite and 
bioactive glass. The EDS result confirms that a 
homogeneous distribution of components is formed 
during synthesis. As expected, the elemental 
components of all the samples are almost the same. 
EDS analysis also gives the insight into the variations 
in the composition of Ca/P ratios of the prepared 
composite nanopowders. Because of the presence of 
 
Fig. 4  SEM micrographs and EDS analyses of the ((a) and (b)) HBI, ((c) and (d)) HBII, ((e) and (f)) HBIII, and 
((g) and (h)) HBIV samples. 
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Ca and P in bioactive glass precursors, the ratio of 
Ca/P is higher than that in pure HAp (> 1.67). 
Moreover, the Ca/P contents vary in each sample 
suggesting that the synthesis process modifies the Ca/P 
ratio. 
3.	4	 	 TEM	analysis	
To get a clear insight into the nanostructure nature of 
the produced composites and also to investigate the 
particle morphologies, TEM micrographs are provided 
as shown in Fig. 5. All the samples show nano-sized 
spheroidal morphology. The powders show a 
cluster-like structure which is composed of several 
small particles in the range of 20–60 nm. The 
agglomerate particles are hard to break down even 
with long time ultrasonication, especially for HBI and 
HBII particles. The formation of agglomerated 
particles can be explained by different possible 
reaction mechanisms in various synthesis scripts [31]. 
This confirms the changes in the morphology of the 
composite nanopowders. 
3.	5	 	 BET	and	average	grain	size 
The specific surface area (SSA) values of the 
composite nanopowders are presented in Table 2. The 
results of the average particle size BET( )D  
measurements on these samples are also given. It 
should be noted that the aggregation of the powders 
decreases the specific surface area [37]. The calculated 
BETD  ranges between 30 nm and 70 nm. The results 
are in good agreement with TEM observations and the 
mean crystallite size determined by XRD. A slight 
difference between these results is due to assumption 
of powders to be spherical in BET method. According 
to the previous investigations, decreasing particle size 
through increasing the specific surface area would 
increase the interaction between the material and the 
physiological solution, and therefore, enhances the 
kinetics of bioactivity reactions, e.g., osteoblast 
functions and protein adsorption [38–40]. 
As a result, we conclude that a reduction of the 
specific surface area is supported by cluster-like 
structure formed during powder synthesis methods. 
Current study has led to the refinement and 
optimization in the particle size, particle size 
 
Fig. 5  TEM micrographs of (a) HBI, (b) HBII, (c) HBIII and (d) HBIV samples. 
Table 2  Specific surface area (SSA) and average 
particle size DBET( ) of hydroxyapatite with 
20 wt% bioglass nanopowders 
Equivalent spherical 
particle diameter (nm) 
Specific surface 
area (m2/g) Sample
32.72 65.49 HBI 
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distribution, and degree of particle agglomeration of 
the HAp-BG composite nanopowders, which are 
important factors in the selection of the most 
appropriate biomaterials during tissue interactions. In 
the next article we will describe our research efforts in 
two-step sintering process on consolidation of 
bioactive glass content on sinter-ability, mechanical 
properties, and bioactivity of hydroxyapatite bulks. 
4	 	 Conclusions	
In the present study, a comparative study of sol–gel 
derived hydroxyapatite-bioglass (HAp-BG) composite 
nanopowders reveals that a number of desirable 
features in biomaterials can be easily controlled with 
different processing histories. A uniform microstructure 
with fine grain size and well distribution is observed 
for material obtained from route-III processed powders 
(mixing calcined BG nanopowders with HAp solution), 
whereas a significant tendency to agglomeration is 
observed in other powders. The high efficiency of the 
process opens a way to produce commercial amount of 
HAp-BG nanopowders. The material can be compacted 
and transformed in solid HAp-BG ceramic samples 
which emerge the potential ability to induce bone 
regeneration when implanted heterotopically. Although 
further improvements to the HAp-BG composite are 
necessary, this is a promising first investigation 
showing its inherent ability to develop in hard tissue 
applications from the mechanical and biological 
perspectives. 
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